1. Home
  2. WIA vs IPSC Comparison

WIA vs IPSC Comparison

Compare WIA & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Inflation-Linked Income Fund

WIA

Western Asset Inflation-Linked Income Fund

HOLD

Current Price

$8.21

Market Cap

191.5M

Sector

Finance

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.43

Market Cap

189.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIA
IPSC
Founded
2003
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.5M
189.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WIA
IPSC
Price
$8.21
$2.43
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$3.50
AVG Volume (30 Days)
62.8K
878.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
12.29%
N/A
EPS Growth
N/A
29.07
EPS
N/A
0.11
Revenue
N/A
$6,589,000.00
Revenue This Year
N/A
$1,590.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.82
Revenue Growth
N/A
194.81
52 Week Low
$8.02
$0.34
52 Week High
$8.54
$2.71

Technical Indicators

Market Signals
Indicator
WIA
IPSC
Relative Strength Index (RSI) 37.05 65.74
Support Level $8.13 $0.49
Resistance Level $8.32 $2.71
Average True Range (ATR) 0.07 0.18
MACD -0.02 0.02
Stochastic Oscillator 25.04 97.35

Price Performance

Historical Comparison
WIA
IPSC

About WIA Western Asset Inflation-Linked Income Fund

Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: